[Asia Economy Reporter Jang Hyowon] Central Insight announced on the 10th that it has resolved concerns about capital erosion and strengthened financial soundness through a free capital reduction and a paid-in capital increase. It explained that this increases the likelihood of being removed from the list of companies under management this year.


In November last year, Central Insight completed a capital reduction to cover accumulated losses, reducing its capital from approximately 43.4 billion KRW to 4.3 billion KRW. Following the capital reduction, shares were consolidated at a ratio of 10 common shares to 1 new share, and the new shares were successfully listed.


Additionally, in January this year, through a third-party allotment paid-in capital increase of approximately 14.5 billion KRW, the largest shareholder changed to AsheSeven, a peptide cosmeceutical specialized company.


Central Insight expects the capital erosion ratio to fall below 50% through the free capital reduction and paid-in capital increase. It explained that this will resolve the capital erosion, which was the basis for being designated as a company under management.


Along with this, Central Insight is accelerating the discovery of new growth engines in various fields including biotechnology.



A company official stated, “With the strengthened financial structure through capital expansion, starting this year, we will establish a continuous corporate stabilization foundation based on synergy with AsheSeven, the largest shareholder. We will do our best to increase sales through the full-scale launch of new businesses alongside existing ones.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing